Channel Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PF
Channel Wealth's XBI Position: Q3 2023 in Review
Channel Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,431 shares — an estimated $202K sold.
Channel Wealth first reported a position in XBI in Q1 2023 and held it in 2 quarters. The position peaked at $263K in Q1 2023. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.
- Channel Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
- Channel Wealth sold 2,431 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $202K.
- Channel Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 2 quarters.
- Channel Wealth's State Street SPDR S&P Biotech ETF position peaked at $263K in Q1 2023.
- 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.
Based on Channel Wealth's 13F filing for Q3 2023, filed 24 Oct 2023.